=== Ticker Info ===
address1	No. 3, Tanxing Road
address2	Section 1 Tanzi District
city	Taichung
zip	427003
country	Taiwan
phone	886 4 2538 1220
fax	886 4 2239 5076
website	https://www.adimmune.com.tw
industry	Biotechnology
industryKey	biotechnology
industryDisp	Biotechnology
sector	Healthcare
sectorKey	healthcare
sectorDisp	Healthcare
longBusinessSummary	Adimmune Corporation manufactures and sells human vaccines in Taiwan. It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; Tetanus Toxoid; and purified Tuberculin, as well as contract manufacturing services. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was founded in 1965 and is headquartered in Taichung, Taiwan.
companyOfficers	[{'maxAge': 1, 'name': 'Mr. Chi-Hsien  Chan', 'title': 'CEO & Chairman', 'fiscalYear': 2021, 'totalPay': 67320000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Chung-Cheng  Liu', 'title': 'President, GM & Director', 'fiscalYear': 2021, 'totalPay': 4647000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Chin-Chuan  Chang', 'title': 'COO and VP of R&D', 'fiscalYear': 2021, 'totalPay': 5741000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Fei  Pan', 'title': 'Chief Legal Officer & General Counsel', 'fiscalYear': 2021, 'totalPay': 5247000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Chun Cheng  Chen M.B.A., M.D., M.Sc., Ph.D.', 'title': 'Chief Medical Officer', 'fiscalYear': 2021, 'totalPay': 4867000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Yin-Teng  Chang', 'title': 'Chief Financial Officer', 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Li-Ya  Tang', 'title': 'Director of Administration Center', 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Chih-Hsiang  Leng', 'title': 'Head of R&D Division', 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Chin-I  Chiu', 'title': 'Vice President of Quality Assurance Department', 'fiscalYear': 2021, 'totalPay': 5631000, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate	1640908800
maxAge	86400
priceHint	2
previousClose	28.25
open	28.35
dayLow	28.0
dayHigh	28.35
regularMarketPreviousClose	28.25
regularMarketOpen	28.35
regularMarketDayLow	28.0
regularMarketDayHigh	28.35
exDividendDate	1631577600	 (2021-09-14 08:00:00)
beta	0.45
forwardPE	8.313609
volume	739314
regularMarketVolume	739314
averageVolume	1120984
averageVolume10days	738158
averageDailyVolume10Day	738158
bid	28.05
ask	28.1
marketCap	11844374528
fiftyTwoWeekLow	25.0
fiftyTwoWeekHigh	38.95
priceToSalesTrailing12Months	6.6351542
fiftyDayAverage	27.37
twoHundredDayAverage	31.52625
currency	TWD
enterpriseValue	12820069376
profitMargins	-0.35846
floatShares	304944178
sharesOutstanding	421508000
heldPercentInsiders	0.18093
heldPercentInstitutions	0.15509
impliedSharesOutstanding	439231008
bookValue	12.988
priceToBook	2.1635356
lastFiscalYearEnd	1703980800	 (2023-12-31 08:00:00)
nextFiscalYearEnd	1735603200	 (2024-12-31 08:00:00)
mostRecentQuarter	1703980800	 (2023-12-31 08:00:00)
netIncomeToCommon	-639891008
trailingEps	-1.52
forwardEps	3.38
enterpriseToRevenue	7.182
enterpriseToEbitda	-24.279
52WeekChange	-0.24054056
SandP52WeekChange	0.26265144
lastDividendValue	0.5
lastDividendDate	1631577600	 (2021-09-14 08:00:00)
exchange	TAI
quoteType	EQUITY
symbol	4142.TW
underlyingSymbol	4142.TW
shortName	ADIMMUNE CORPORATION
longName	Adimmune Corporation
firstTradeDateEpochUtc	1336006800	 (2012-05-03 09:00:00)
timeZoneFullName	Asia/Taipei
timeZoneShortName	CST
uuid	2a1e9178-d151-33a7-9a54-9c910c309f38
messageBoardId	finmb_33352978
gmtOffSetMilliseconds	28800000
currentPrice	28.1
recommendationMean	3.0
recommendationKey	hold
totalCash	2470000896
totalCashPerShare	5.86
ebitda	-528025984
totalDebt	3142629888
quickRatio	2.131
currentRatio	2.63
totalRevenue	1785094016
debtToEquity	54.394
revenuePerShare	4.235
returnOnAssets	-0.04849
returnOnEquity	-0.12497
freeCashflow	-1077781120
operatingCashflow	-892348992
revenueGrowth	-0.043
grossMargins	0.23020001
ebitdaMargins	-0.2958
operatingMargins	-0.68598
financialCurrency	TWD
trailingPegRatio	None

=== Financials ===
                                                              2023-12-31        2022-12-31    2021-12-31    2020-12-31
Tax Effect Of Unusual Items                                          0.0    -319173.452143           0.0           0.0
Tax Rate For Calcs                                                   0.0          0.064014           0.0           0.0
Normalized EBITDA                                           -118552000.0       443110000.0   254886000.0  1447010000.0
Total Unusual Items                                         -393876000.0        -4986000.0           0.0           NaN
Total Unusual Items Excluding Goodwill                      -393876000.0        -4986000.0           0.0           NaN
Net Income From Continuing Operation Net Minority Interest  -639891000.0       290975000.0    43066000.0  1241246000.0
Reconciled Depreciation                                      224125000.0       259316000.0   225913000.0   227583000.0
Reconciled Cost Of Revenue                                  1374159000.0      1360542000.0  1176916000.0  1246085000.0
EBITDA                                                      -512428000.0       438124000.0   254886000.0  1447010000.0
EBIT                                                        -736553000.0       178808000.0    28973000.0  1219427000.0
Net Interest Income                                          -15204000.0       -15681000.0   -10091000.0   -18160000.0
Interest Expense                                              33426000.0        22592000.0    14688000.0    22163000.0
Interest Income                                               18222000.0         6911000.0     4597000.0     4003000.0
Normalized Income                                           -246015000.0  295641826.547857    43066000.0  1241246000.0
Net Income From Continuing And Discontinued Operation       -639891000.0       290975000.0    43066000.0  1241246000.0
Total Expenses                                              2113965000.0      2153071000.0  1847867000.0  1894961000.0
Diluted Average Shares                                               NaN       427679000.0   429602000.0   410038000.0
Basic Average Shares                                                 NaN       427231000.0   429508000.0   408985000.0
Diluted EPS                                                          NaN              0.68           0.1          3.03
Basic EPS                                                            NaN              0.68           0.1          3.03
Diluted NI Availto Com Stockholders                         -639891000.0       290975000.0    43066000.0  1241246000.0
Net Income Common Stockholders                              -639891000.0       290975000.0    43066000.0  1241246000.0
Otherunder Preferred Stock Dividend                                  0.0               0.0           0.0           0.0
Net Income                                                  -639891000.0       290975000.0    43066000.0  1241246000.0
Minority Interests                                           130088000.0       144759000.0    28781000.0    43982000.0
Net Income Including Noncontrolling Interests               -769979000.0       146216000.0    14285000.0  1197264000.0
Net Income Continuous Operations                            -769979000.0       146216000.0    14285000.0  1197264000.0
Tax Provision                                                        0.0        10000000.0           0.0           0.0
Pretax Income                                               -769979000.0       156216000.0    14285000.0  1197264000.0
Other Non Operating Income Expenses                          -32028000.0        78330000.0    78467000.0  1241238000.0
Special Income Charges                                      -393876000.0        -4986000.0           0.0           NaN
Write Off                                                    393876000.0         4986000.0           0.0           NaN
Net Non Operating Interest Income Expense                    -15204000.0       -15681000.0   -10091000.0   -18160000.0
Interest Expense Non Operating                                33426000.0        22592000.0    14688000.0    22163000.0
Interest Income Non Operating                                 18222000.0         6911000.0     4597000.0     4003000.0
Operating Income                                            -328871000.0        98553000.0   -54091000.0   -25814000.0
Operating Expense                                            739806000.0       792529000.0   670951000.0   648876000.0
Research And Development                                     296934000.0       346420000.0   321284000.0   337684000.0
Selling General And Administration                           442872000.0       446109000.0   349667000.0   311192000.0
Selling And Marketing Expense                                129632000.0       150791000.0    45407000.0    29288000.0
General And Administrative Expense                           313240000.0       295318000.0   304260000.0   281904000.0
Gross Profit                                                 410935000.0       891082000.0   616860000.0   623062000.0
Cost Of Revenue                                             1374159000.0      1360542000.0  1176916000.0  1246085000.0
Total Revenue                                               1785094000.0      2251624000.0  1793776000.0  1869147000.0
Operating Revenue                                           1785094000.0      2251624000.0  1793776000.0  1869147000.0